ClinicalTrials.gg
Drug

Clobetasol clinical trials

Also written SVT-15473.

studies test it
46
open now
4
in phase 3
10
first study started
2002

How each study uses Clobetasol is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Clobetasol studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
27 Dec 1985 · TEMOVATE · NDA 019322 (FDA, Drugs@FDA)
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Clobetasol
8
Clobetasol Propionate
7
Clobex® Spray
6
Clobetasol Propionate 0.05% Cream
2
Clobetasol Propionate 0.05% Ointment
2

Brand

Dermovate
1
Temovate
1

Development codes

SVT-15473
3

Studies by the year they started

46 studies that test it; most in 2008 (5)

Studies that test Clobetasol, by start year
YearStudies
20021
20041
20052
20063
20073
20085
20093
20102
20111
20133
20142
20153
20163
20183
20191
20203
20221
20232
20241
20252
20261

By phase

A phase 1/2 study counts in both.

Phase 1
7
Phase 2
10
Phase 3
10
Phase 4
18
No phase
5

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 19 · Other 27

Galderma R&D (6) · Salvat (3) · Stiefel, a GSK Company (3) · Medstar Health Research Institute (2) · LEO Pharma (2) · Actavis Inc. (2) · Assistance Publique - Hôpitaux de Paris (2) · Malmö University (1)

Often tested with

Tested in the same studies.

Betamethasone dipropionate (3) · Betamethasone (3) · Calcitriol (3) · Calcipotriene (3) · Pimecrolimus (2) · Halobetasol (2) · Triamcinolone Acetonide (2) · Triamcinolone (2)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Tested against it · 1 phase 3 study under way

Clobetasol is the comparator. A study of two new drugs counts under both.

Reaching primary completion within a year · 2

Studies that test Clobetasol.

Studies

Open first, then newest update. How each study uses Clobetasol is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 46

See all 46 studies that test Clobetasol →

Given beside what is tested · 7 — Clobetasol is usual care or a partner of the new treatment
As the comparator · 26 — what is tested is compared with Clobetasol

Showing 20 of 26.

Codes

What other systems call Clobetasol · ClinicalTrials.gg INT007229

  • MeSH (NLM) D002990ClobetasolConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) ADN79D536HCLOBETASOLConfirmed FDA, NLM, Wikidata
  • RxNorm 2590Confirmed FDA, Wikidata
  • Wikidata Q4224007clobetasolConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C65339ClobetasolOne source FDA
  • DrugBank DB11750One source Wikidata

Also registered as clobetasol propionate (UNII 779619577M · RxNorm 21245).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.